183 related articles for article (PubMed ID: 34454945)
1. Structural Insights into the Unique Modes of Relaxin-Binding and Tethered-Agonist Mediated Activation of RXFP1 and RXFP2.
Sethi A; Bruell S; Ryan T; Yan F; Tanipour MH; Mok YF; Draper-Joyce C; Khandokar Y; Metcalfe RD; Griffin MDW; Scott DJ; Hossain MA; Petrie EJ; Bathgate RAD; Gooley PR
J Mol Biol; 2021 Oct; 433(21):167217. PubMed ID: 34454945
[TBL] [Abstract][Full Text] [Related]
2. The complex binding mode of the peptide hormone H2 relaxin to its receptor RXFP1.
Sethi A; Bruell S; Patil N; Hossain MA; Scott DJ; Petrie EJ; Bathgate RAD; Gooley PR
Nat Commun; 2016 Apr; 7():11344. PubMed ID: 27088579
[TBL] [Abstract][Full Text] [Related]
3. Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin.
Bruell S; Sethi A; Smith N; Scott DJ; Hossain MA; Wu QP; Guo ZY; Petrie EJ; Gooley PR; Bathgate RAD
Sci Rep; 2017 Jun; 7(1):3294. PubMed ID: 28607406
[TBL] [Abstract][Full Text] [Related]
4. The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation.
Kong RC; Petrie EJ; Mohanty B; Ling J; Lee JC; Gooley PR; Bathgate RA
J Biol Chem; 2013 Sep; 288(39):28138-51. PubMed ID: 23926099
[TBL] [Abstract][Full Text] [Related]
5. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.
Scott DJ; Rosengren KJ; Bathgate RA
Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049
[TBL] [Abstract][Full Text] [Related]
6. The NMR solution structure of the relaxin (RXFP1) receptor lipoprotein receptor class A module and identification of key residues in the N-terminal region of the module that mediate receptor activation.
Hopkins EJ; Layfield S; Ferraro T; Bathgate RA; Gooley PR
J Biol Chem; 2007 Feb; 282(6):4172-84. PubMed ID: 17148455
[TBL] [Abstract][Full Text] [Related]
7. Modeling the primary hormone-binding site of RXFP1 and RXFP2.
Scott DJ; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2009 Apr; 1160():74-7. PubMed ID: 19416162
[TBL] [Abstract][Full Text] [Related]
8. Investigation of interactions at the extracellular loops of the relaxin family peptide receptor 1 (RXFP1).
Diepenhorst NA; Petrie EJ; Chen CZ; Wang A; Hossain MA; Bathgate RA; Gooley PR
J Biol Chem; 2014 Dec; 289(50):34938-52. PubMed ID: 25352603
[TBL] [Abstract][Full Text] [Related]
9. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation.
Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY
FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387
[TBL] [Abstract][Full Text] [Related]
10. Mapping key regions of the RXFP2 low-density lipoprotein class-A module that are involved in signal activation.
Kong RC; Bathgate RA; Bruell S; Wade JD; Gooley PR; Petrie EJ
Biochemistry; 2014 Jul; 53(28):4537-48. PubMed ID: 24983702
[TBL] [Abstract][Full Text] [Related]
11. Resolving the unconventional mechanisms underlying RXFP1 and RXFP2 receptor function.
Hartley BJ; Scott DJ; Callander GE; Wilkinson TN; Ganella DE; Kong CK; Layfield S; Ferraro T; Petrie EJ; Bathgate RA
Ann N Y Acad Sci; 2009 Apr; 1160():67-73. PubMed ID: 19416161
[TBL] [Abstract][Full Text] [Related]
12. Application of the novel bioluminescent ligand-receptor binding assay to relaxin-RXFP1 system for interaction studies.
Wu QP; Zhang L; Shao XX; Wang JH; Gao Y; Xu ZG; Liu YL; Guo ZY
Amino Acids; 2016 Apr; 48(4):1099-1107. PubMed ID: 26767372
[TBL] [Abstract][Full Text] [Related]
13. Solution structure, aggregation behavior, and flexibility of human relaxin-2.
Haugaard-Kedström LM; Hossain MA; Daly NL; Bathgate RA; Rinderknecht E; Wade JD; Craik DJ; Rosengren KJ
ACS Chem Biol; 2015 Mar; 10(3):891-900. PubMed ID: 25547165
[TBL] [Abstract][Full Text] [Related]
14. Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxin.
Chan LJ; Rosengren KJ; Layfield SL; Bathgate RA; Separovic F; Samuel CS; Hossain MA; Wade JD
J Biol Chem; 2012 Nov; 287(49):41152-64. PubMed ID: 23024363
[TBL] [Abstract][Full Text] [Related]
15. Chimeric RXFP1 and RXFP2 Receptors Highlight the Similar Mechanism of Activation Utilizing Their N-Terminal Low-Density Lipoprotein Class A Modules.
Bruell S; Kong RC; Petrie EJ; Hoare B; Wade JD; Scott DJ; Gooley PR; Bathgate RA
Front Endocrinol (Lausanne); 2013; 4():171. PubMed ID: 24273532
[TBL] [Abstract][Full Text] [Related]
16. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
[TBL] [Abstract][Full Text] [Related]
17. Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-arrestin recruitment.
Callander GE; Thomas WG; Bathgate RA
Am J Physiol Cell Physiol; 2009 May; 296(5):C1058-66. PubMed ID: 19279230
[TBL] [Abstract][Full Text] [Related]
18. Recombinant RXFP1-LDL-A module does not form dimers.
Petrie EJ; Periguini MA; Bathgate RA; Gooley PR
Ital J Anat Embryol; 2013; 118(1 Suppl):4-6. PubMed ID: 24640556
[TBL] [Abstract][Full Text] [Related]
19. Relaxin family peptides and their receptors.
Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
[TBL] [Abstract][Full Text] [Related]
20. Chimeric relaxin peptides highlight the role of the A-chain in the function of H2 relaxin.
Hossain MA; Wade JD; Bathgate RA
Peptides; 2012 May; 35(1):102-6. PubMed ID: 22414484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
